title: Diabetes and human immunodeficiency virus infection: Epidemiological, therapeutic aspects and patient experience.
abstract: BACKGROUND
  Nationally, no data on the association between human immunodeficiency virus infection and diabetes have been published.
  
  
  OBJECTIVE
  To review the epidemiological, clinical and therapeutic data and evaluate the experience of people living with HIV and suffering from diabetes.
  
  
  METHODS
  Our study population was composed of 190 outpatients (87 males and 103 females) attending the Infectious Diseases department of the University Hospital Center of Casablanca (Ibn Rochd). Using the computerized medical records, we identified patients with HIV-Diabetes and collected their epidemiological, clinical and therapeutic data. At the enrollment date of each patient, we measured anthropometric parameters (weight, height, waist circumference, hip circumference, and arm circumference). We also asked each patient, about the impression on their bodies' appearance and the degree of concern with regard to the diabetes.
  
  
  RESULTS
  The population of patients with HIV, the prevalence of diabetes was 10.5%, among the patients taking an antiretroviral therapy, the prevalence was 13.5%. Diabetes has been diagnosed in 113 patients before the discovery of their HIV infection. At time of recruitment, 111 of them were under antiretroviral therapy for a mean period of 3.1years. Zidovudine was the most prescribed drug followed by lamivudine. Type 2 diabetes was diagnosed in 144 patients. Eighty-seven patients feel conscious about their body appearance which makes them feel bad about the way they look. Metformin was prescribed in 46 cases. The majority of patients (73.1%) considered diabetes as a second health problem. Only 46 patients were well balanced.
  
  
  CONCLUSIONS
  The multidisciplinary consultation and patient education should enable an appropriate management of diabetes in HIV infected patients.
authors.affiliation: CHU Ibn Rochd, service des maladies infectieuses, 20100 Casablanca, Morocco. Electronic address: drtraore@hotmail.com.
authors.forename: Youssouf
authors.initials: Y
authors.lastname: Traoré
authors.affiliation: CHU Ibn Rochd, service des maladies infectieuses, 20100 Casablanca, Morocco.
authors.forename: Rajaa
authors.initials: R
authors.lastname: Bensghir
authors.affiliation: CHU Ibn Rochd, service des maladies infectieuses, 20100 Casablanca, Morocco.
authors.forename: Fatima
authors.initials: F
authors.lastname: Ihbibane
authors.affiliation: CHU Ibn Rochd, service des maladies infectieuses, 20100 Casablanca, Morocco.
authors.forename: Ahd
authors.initials: A
authors.lastname: OuladLashen
authors.affiliation: CHU Ibn Rochd, service des maladies infectieuses, 20100 Casablanca, Morocco.
authors.forename: Mustapha
authors.initials: M
authors.lastname: Sodqi
authors.affiliation: CHU Ibn Rochd, service des maladies infectieuses, 20100 Casablanca, Morocco.
authors.forename: Latifa
authors.initials: L
authors.lastname: Marih
authors.affiliation: CHU Ibn Rochd, service des maladies infectieuses, 20100 Casablanca, Morocco.
authors.forename: Abdelfattah
authors.initials: A
authors.lastname: Chakib
authors.affiliation: CHU Ibn Rochd, service des maladies infectieuses, 20100 Casablanca, Morocco.
authors.forename: Kamal El Filali
authors.initials: Kel F
authors.lastname: Marhoum
mesh_terms: D000328:Adult; D000368:Aged; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000453:epidemiology* / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000453:epidemiology / Q000628:therapy; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000453:epidemiology* / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged